Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Associations between recall of proper names in story recall and CSF amyloid and tau in adults without cognitive impairment.
Hale MR, Langhough R, Du L, Hermann BP, Van Hulle CA, Carboni M, Kollmorgen G, Basche KE, Bruno D, Sanson-Miles L, Jonaitis EM, Chin NA, Okonkwo OC, Bendlin BB, Carlsson CM, Zetterberg H, Blennow K, Betthauser TJ, Johnson SC, Mueller KD. Hale MR, et al. Among authors: van hulle ca. Neurobiol Aging. 2024 Jan;133:87-98. doi: 10.1016/j.neurobiolaging.2023.09.018. Epub 2023 Oct 5. Neurobiol Aging. 2024. PMID: 37925995 Free PMC article.
Liver-Specific Polygenic Risk Score Is Associated with Alzheimer's Disease Diagnosis.
Panyard DJ, Deming YK, Darst BF, Van Hulle CA, Zetterberg H, Blennow K, Kollmorgen G, Suridjan I, Carlsson CM, Johnson SC, Asthana S, Engelman CD, Lu Q. Panyard DJ, et al. Among authors: van hulle ca. J Alzheimers Dis. 2023;92(2):395-409. doi: 10.3233/JAD-220599. J Alzheimers Dis. 2023. PMID: 36744333 Free PMC article.
Effect of Pathway-specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-related Biomarkers among Asymptomatic Individuals.
Xu Y, Vasiljevic E, Deming YK, Jonaitis EM, Koscik RL, Van Hulle CA, Lu Q, Carboni M, Kollmorgen G, Wild N, Carlsson CM, Johnson SC, Zetterberg H, Blennow K, Engelman CD. Xu Y, et al. Among authors: van hulle ca. medRxiv [Preprint]. 2023 Feb 1:2023.01.30.23285142. doi: 10.1101/2023.01.30.23285142. medRxiv. 2023. Update in: J Alzheimers Dis. 2023;94(4):1587-1605. doi: 10.3233/JAD-230097 PMID: 36778431 Free PMC article. Updated. Preprint.
Neuropathology-based APOE genetic risk score better quantifies Alzheimer's risk.
Deming Y, Vasiljevic E, Morrow A, Miao J, Van Hulle C, Jonaitis E, Ma Y, Whitenack V, Kollmorgen G, Wild N, Suridjan I, Shaw LM, Asthana S, Carlsson CM, Johnson SC, Zetterberg H, Blennow K, Bendlin BB, Lu Q, Engelman CD; Alzheimer's Disease Neuroimaging Initiative. Deming Y, et al. Alzheimers Dement. 2023 Aug;19(8):3406-3416. doi: 10.1002/alz.12990. Epub 2023 Feb 16. Alzheimers Dement. 2023. PMID: 36795776 Free PMC article.
Identification of plasma metabolites associated with modifiable risk factors and endophenotypes reflecting Alzheimer's disease pathology.
Dong R, Denier-Fields DN, Van Hulle CA, Kollmorgen G, Suridjan I, Wild N, Lu Q, Anderson RM, Zetterberg H, Blennow K, Carlsson CM, Johnson SC, Engelman CD. Dong R, et al. Among authors: van hulle ca. Eur J Epidemiol. 2023 May;38(5):559-571. doi: 10.1007/s10654-023-00988-4. Epub 2023 Mar 25. Eur J Epidemiol. 2023. PMID: 36964431 Free PMC article.
Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer's disease.
Miners J, van Hulle C, Ince S, Jonaitis E, Okonkwo OC, Bendlin B, Johnson S, Carlsson C, Asthana S, Love S, Blennow K, Zetterberg H. Miners J, et al. Res Sq [Preprint]. 2023 Apr 18:rs.3.rs-2722280. doi: 10.21203/rs.3.rs-2722280/v1. Res Sq. 2023. Update in: Transl Psychiatry. 2024 Jan 5;14(1):3. doi: 10.1038/s41398-023-02706-w PMID: 37131622 Free PMC article. Updated. Preprint.
Large-scale proteome and metabolome analysis of CSF implicates altered glucose and carbon metabolism and succinylcarnitine in Alzheimer's disease.
Panyard DJ, McKetney J, Deming YK, Morrow AR, Ennis GE, Jonaitis EM, Van Hulle CA, Yang C, Sung YJ, Ali M, Kollmorgen G, Suridjan I, Bayfield A, Bendlin BB, Zetterberg H, Blennow K, Cruchaga C, Carlsson CM, Johnson SC, Asthana S, Coon JJ, Engelman CD. Panyard DJ, et al. Among authors: van hulle ca. Alzheimers Dement. 2023 Dec;19(12):5447-5470. doi: 10.1002/alz.13130. Epub 2023 May 22. Alzheimers Dement. 2023. PMID: 37218097 Free PMC article.
Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals.
Xu Y, Vasiljevic E, Deming YK, Jonaitis EM, Koscik RL, Van Hulle CA, Lu Q, Carboni M, Kollmorgen G, Wild N, Carlsson CM, Johnson SC, Zetterberg H, Blennow K, Engelman CD. Xu Y, et al. Among authors: van hulle ca. J Alzheimers Dis. 2023;94(4):1587-1605. doi: 10.3233/JAD-230097. J Alzheimers Dis. 2023. PMID: 37482996 Free PMC article.
105 results